ADPT
Price
$10.44
Change
+$0.05 (+0.48%)
Updated
Jul 21, 03:45 PM (EDT)
Capitalization
1.58B
15 days until earnings call
TECH
Price
$50.01
Change
-$2.01 (-3.86%)
Updated
Jul 21, 04:46 PM (EDT)
Capitalization
8.16B
16 days until earnings call
Interact to see
Advertisement

ADPT vs TECH

Header iconADPT vs TECH Comparison
Open Charts ADPT vs TECHBanner chart's image
Adaptive Biotechnologies
Price$10.44
Change+$0.05 (+0.48%)
Volume$200
Capitalization1.58B
Bio-Techne
Price$50.01
Change-$2.01 (-3.86%)
Volume$6.07K
Capitalization8.16B
ADPT vs TECH Comparison Chart in %
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. TECH commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ADPT: $10.39 vs. TECH: $52.02)
Brand notoriety: ADPT: Notable vs. TECH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 79% vs. TECH: 83%
Market capitalization -- ADPT: $1.58B vs. TECH: $8.16B
ADPT [@Biotechnology] is valued at $1.58B. TECH’s [@Biotechnology] market capitalization is $8.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than ADPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 4 bearish.
  • TECH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADPT and TECH are a good buy in the short-term.

Price Growth

ADPT (@Biotechnology) experienced а -12.10% price change this week, while TECH (@Biotechnology) price change was -3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

ADPT is expected to report earnings on Aug 05, 2025.

TECH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($8.16B) has a higher market cap than ADPT($1.58B). ADPT YTD gains are higher at: 73.311 vs. TECH (-27.576). TECH has higher annual earnings (EBITDA): 283M vs. ADPT (-111.63M). ADPT has more cash in the bank: 193M vs. TECH (141M). ADPT has less debt than TECH: ADPT (86.9M) vs TECH (423M). TECH has higher revenues than ADPT: TECH (1.21B) vs ADPT (190M).
ADPTTECHADPT / TECH
Capitalization1.58B8.16B19%
EBITDA-111.63M283M-39%
Gain YTD73.311-27.576-266%
P/E RatioN/A62.67-
Revenue190M1.21B16%
Total Cash193M141M137%
Total Debt86.9M423M21%
FUNDAMENTALS RATINGS
ADPT vs TECH: Fundamental Ratings
ADPT
TECH
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9780
PRICE GROWTH RATING
1..100
3862
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
44n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is somewhat better than the same rating for ADPT (59) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew somewhat faster than ADPT’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew similarly to ADPT’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as ADPT (97) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's Price Growth Rating (38) in the Hospital Or Nursing Management industry is in the same range as TECH (62) in the Biotechnology industry. This means that ADPT’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (47) in the Biotechnology industry is somewhat better than the same rating for ADPT (100) in the Hospital Or Nursing Management industry. This means that TECH’s stock grew somewhat faster than ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTTECH
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
67%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPRX31.350.44
+1.41%
Spear Alpha ETF
BSCV16.490.05
+0.30%
Invesco BulletShares 2031 Corp Bd ETF
IBHH23.630.02
+0.10%
iShares iBonds 2028 Term HY & Inc ETF
SPCZ27.83N/A
N/A
RiverNorth Ehd PMgr SPAC ETF
TSMU30.61-1.45
-4.52%
GraniteShares 2x Long TSM Daily ETF

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
-1.05%
BEAM - ADPT
49%
Loosely correlated
+1.47%
TECH - ADPT
48%
Loosely correlated
-2.38%
DNLI - ADPT
45%
Loosely correlated
-3.65%
ABSI - ADPT
45%
Loosely correlated
+8.33%
DNA - ADPT
44%
Loosely correlated
+5.52%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-2.38%
SYRE - TECH
49%
Loosely correlated
-3.55%
ADPT - TECH
48%
Loosely correlated
-1.05%
DNLI - TECH
47%
Loosely correlated
-3.65%
TRDA - TECH
46%
Loosely correlated
-1.88%
XNCR - TECH
46%
Loosely correlated
-1.10%
More